Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390941 | SCV001592844 | pathogenic | not provided | 2023-12-19 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the MPV17 gene (p.Leu151Profs*39). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 26 amino acid(s) of the MPV17 protein and extend the protein by 12 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individuals with mitochondrial DNA depletion syndrome (PMID: 27536553, 29282788). ClinVar contains an entry for this variant (Variation ID: 38356). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003460536 | SCV004193751 | pathogenic | Charcot-Marie-Tooth disease, axonal, type 2EE | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005025086 | SCV005655947 | pathogenic | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type); Charcot-Marie-Tooth disease, axonal, type 2EE | 2024-02-22 | criteria provided, single submitter | clinical testing | |
Soonchunhyang University Bucheon Hospital, |
RCV000031912 | SCV000267399 | uncertain significance | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | 2016-03-18 | flagged submission | reference population | |
Natera, |
RCV003227466 | SCV002076535 | pathogenic | Mitochondrial DNA depletion syndrome 15 (hepatocerebral type) | 2021-07-21 | no assertion criteria provided | clinical testing |